Cvs Health (CVS) Operating Expenses (2009 - 2026)

Cvs Health (CVS) has reported Operating Expenses for 18 consecutive years, with $101.4 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Expenses rose 5.03% year-over-year to $101.4 billion; the trailing twelve-month figure through Jun 2026 stood at $406.8 billion (up 7.71% YoY), and the FY2025 full-year result was $397.4 billion, up 9.09% from the prior year.
• Operating Expenses improved to $101.4 billion in Q2 2026 per CVS's latest filing, from $95.7 billion in the prior quarter.
• Across five years, Operating Expenses topped out at $106.1 billion in Q3 2025 and bottomed at $73.3 billion in Q1 2022.
• Historically, Operating Expenses has averaged $89.9 billion across 5 years, with a median of $89.3 billion in 2023.
• The sharpest annual moves came in 2022 and 2023: Operating Expenses advanced 20.28% in 2022, then increased 1.17% in 2023.
• Over 5 years, Operating Expenses stood at $80.2 billion in 2022, then advanced by 12.79% to $90.4 billion in 2023, then increased by 5.42% to $95.3 billion in 2024, then gained by 8.64% to $103.6 billion in 2025, then slipped by 2.11% to $101.4 billion in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $101.4 billion, $95.7 billion, and $103.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.